11.94USD+2.49%Mkt Cap: 317.51M USDP/E: —Last update: 2026-06-01
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II c…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap317.51M USD
Enterprise Value169.64M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-52.60M USD
Revenue/Share—
Last Price11.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS88032L5066
Valuation
P/E (Trailing)—
P/E (Forward)-8.42
PEG1.44
EV/EBITDA—
EV/Revenue—
P/S—
P/B5.19
EPS (TTM)-1.41
EPS (Forward)-1.41
52W Range
5.34051% of range18.38
52W High18.38 USD
52W Low5.340 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-54.19%
ROA-50.47%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.80M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-118.75M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio14.52
Quick Ratio13.99
Book Value/Sh2.288 USD
Cash/Share4.892 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateFeb 26, 2018
Splits
Last Split1:80
Split DateJan 3, 2024
Analyst Consensus
Rating—
Target (Mean)29.71 USD
Target Range20.00 USD – 36.00 USD
# Analysts7
Ownership
Shares Out.26.53M
Float10.61M
Insiders0.12%
Institutions84.21%
Short Interest
Short Ratio1.1d
Short % Float2.96%
Short % Out.2.93%
Shares Short775.85K
Short (prev mo.)194.46K
Technical
SMA 5013.54 (-11.8%)
SMA 20010.65 (+12.1%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)618.03K
Avg Vol (10d)481.50K
Technical Indicators
RSI (14)40.2
MACD-0.4422
MACD Signal-0.4883
MACD Hist.+0.0461
BB Upper12.91 USD
BB Middle12.04 USD
BB Lower11.16 USD
BB Width14.52%
ATR (14)0.7714 USD
Vol Ratio (20d)0.45x